USANA Health Sciences (USNA) Earns Daily Coverage Optimism Score of 0.14

Press coverage about USANA Health Sciences (NYSE:USNA) has trended somewhat positive on Monday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. USANA Health Sciences earned a news sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the company an impact score of 46.2614554357492 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

Shares of USNA stock opened at $93.30 on Monday. The stock has a market capitalization of $2,243.77, a PE ratio of 22.98 and a beta of 0.82. USANA Health Sciences has a fifty-two week low of $52.55 and a fifty-two week high of $94.40.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.11. USANA Health Sciences had a return on equity of 27.08% and a net margin of 5.97%. The firm had revenue of $273.11 million for the quarter, compared to the consensus estimate of $258.67 million. During the same quarter in the prior year, the business earned $0.87 earnings per share. The company’s revenue was up 8.0% compared to the same quarter last year. sell-side analysts anticipate that USANA Health Sciences will post 4.25 EPS for the current fiscal year.

A number of research analysts have recently weighed in on the company. TheStreet lowered USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday, February 6th. Pivotal Research increased their price objective on USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, February 7th. Finally, Sidoti lowered USANA Health Sciences from a “buy” rating to a “neutral” rating in a report on Wednesday, January 24th.

In other news, Director Myron W. Wentz sold 38,223 shares of the company’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $71.51, for a total value of $2,733,326.73. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, major shareholder Global Ltd Gull sold 40,000 shares of the company’s stock in a transaction dated Tuesday, April 3rd. The stock was sold at an average price of $86.23, for a total value of $3,449,200.00. Following the completion of the sale, the insider now owns 11,214,053 shares in the company, valued at approximately $966,987,790.19. The disclosure for this sale can be found here. Insiders sold 729,767 shares of company stock worth $58,024,833 in the last 90 days. Company insiders own 53.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “USANA Health Sciences (USNA) Earns Daily Coverage Optimism Score of 0.14” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3342615/usana-health-sciences-usna-earns-daily-coverage-optimism-score-of-0-14.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Enduro Royalty Trust  Plans $0.06 Dividend
Enduro Royalty Trust Plans $0.06 Dividend
Choice Properties REIT  Increases Dividend to $0.06 Per Share
Choice Properties REIT Increases Dividend to $0.06 Per Share
Banyan Network  Trading 6.7% Lower  Over Last 7 Days
Banyan Network Trading 6.7% Lower Over Last 7 Days
Cloud   Trading 34.4% Lower  Over Last Week
Cloud Trading 34.4% Lower Over Last Week
DCP Midstream  versus Its Rivals Financial Comparison
DCP Midstream versus Its Rivals Financial Comparison
Reviewing Limoneira  and S&w Seed
Reviewing Limoneira and S&w Seed


Leave a Reply

© 2006-2018 Ticker Report. Google+.